Author(s):
Atharva Vinod Hande, Saddam Shamshudin Maner, Pranoti Pralhad Jadhav, Deepti Dharmendra Kamble
Email(s):
atharvahande1616@gmail.com , saddammaner05@gmail.com , pranotijadhav1652001@gmail.com , dkamble1616@gmail.com
DOI:
10.52711/2231-5659.2024.00060 
Address:
Atharva Vinod Hande, Saddam Shamshudin Maner, Pranoti Pralhad Jadhav, Deepti Dharmendra Kamble
Anandi Pharmacy College Kalamabe Tarf Kale, Bhamate, Maharashtra.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2024
ABSTRACT:
Quantum dots (QDs) are semiconductor material that have gained great interest due to their unique characteristics like optical properties. QDS are a revolutionary new technology that is being used to treat a variety of diseases. The excretion of QD indicates conversion in natural imaging along with photography have established incredible suitability in bioimaging, new drug development, targeted gene deliverance, biosensing, photodynamic treatment as well as diagnosis. Cancer is a major threat to public health in 21st century because it is one of the leading causes of death. With the optical and chemical advantages of QD, QD -based nanotechnology is helpful in constructing a biomedical imaging platform for cancer behavior study. Also detecting viral infections has become challenging in medical research due to their high infectivity and mutation. Detection viruses based on quantum dots biomarkers is inexpensive and has great potential. Nanotechnology is an emerging field that may have potentials as make in the detection treatment and prevention of cancer. Quantum dots used to detect primary tumor. Also be take part in the treatment of breast cancer in women in which diagnosis of breast cancer, detection of correlation between HER2 gene amplification and protein expression, immunofluorescence imaging of HER2 and ER, triple negative breast cancer therapy using QDs based micelle conjugation. The blood brain barrier (BBB) protects the blood tissue. Only certain small molecule like water and gases can BBB, whereas large molecule entre via receptors, but many drugs are incapable of passing the barrier.
Cite this article:
Atharva Vinod Hande, Saddam Shamshudin Maner, Pranoti Pralhad Jadhav, Deepti Dharmendra Kamble. Quantam Dots and their Medical Importance. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(4):381-3. doi: 10.52711/2231-5659.2024.00060
Cite(Electronic):
Atharva Vinod Hande, Saddam Shamshudin Maner, Pranoti Pralhad Jadhav, Deepti Dharmendra Kamble. Quantam Dots and their Medical Importance. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(4):381-3. doi: 10.52711/2231-5659.2024.00060 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2024-14-4-8
REFERENCE:
1. Li Y, Peng CW. Application of quantum dots-based biotechnology in cancer diagnosis: Current status and future perspectives. J Nanomater. 2010:11.
2. Radenkovic D, Kobayashi H, Remsey-Semmelweis E, et al. Quantum dot nanoparticle for optimization of breast cancer diagnostics.
3. Kerry RG, Ukhurebor KE, Kumari S, Maurya GK, Patra S, et al. (2021) A comprehensive review on the applications of nano-biosensor- based approate manner.
4. Solanki I, Parihar P, Parihar MS. Neurodegenerative diseases: From available treatments to prospective herbal therapy. Neurochem Int. 2016; 95: 100–8. doi: 10.1016/j.neuint.2015.11.001.
5. Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: Models, mechanisms, and a new hope. Dis Model Mech. 2017; 10(5): 499–502. doi: 10.1242/dmm.030205.
6. Solanki I, Parihar P, Parihar MS. Neurodegenerative diseases: From available treatments to prospective herbal therapy. Neurochem Int. 2016; 95: 100–8. doi: 10.1016/j.neuint.2015.11.001.
7. Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: Models, mechanisms, and a new hope. Dis Model Mech. 2017; 10(5):499–502. doi: 10.1242/dmm.030205.
8. A. M. Smith, S. Dave, S. Nie, L. True, and X. Gao. Multicolor quantum dots for molecular diagnostics of cancer. Expert Review of Molecular Diagnostics. 2006; 6(2): 231–244.
9. H. Zhang, D. Yee, and C. Wang. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine. 2008; 3(1): 83–91.
10. A. M. Smith, H. Duan, A. M. Mohs, and S. Nie. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Advanced Drug Delivery Reviews. 2008; 60(11): 1226–1240.
11. Molotkov SN. On the complexity of search for keys in quantum cryptography. JETP Lett. 2016; 103(5): 345-9.
12. Walter P, Welcomme E, Hallégot P, Zaluzec NJ, Deeb C, Castaing J, et al. Early use of PbS nanotechnology for an ancient hair dyeing formula. Nano Lett. 2006; 6(10):2215–9.
13. Murray CB, Norris DJ, Bawendi MG. Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am Chem Soc. 1993; 115(19): 8706
14. Zhang, D.; Huang, L.; Liu, B.; Ni, H.; Sun, L.; Su, E.; Chen, H.; Gu, Z.; Zhao, X. Quantitative and ultrasensitive detection of multiplex cardiac biomarkers in lateral flow assay with core-shell SERS nanotags. Biosens. Bioelectron. 2018,
15. 204–211. [CrossRef] 162. Guteneva, N.V.; Znoyko, S.L.; Orlov, A.V.; Nikitin, M.P.; Nikitin, P.I. Rapid lateral flow assays based on the quantification of magnetic nanoparticle labels for multiplexed immunodetection of small molecules: Application to the determination of drugs of abuse. Mikrochim. Acta. 2019; 186: 621.
16. Rahman T, Khandakar A, Kadir MA, Islam KR, Islam KF, Mazhar R, et al. Reliable tuberculosis detection using chest X-ray with deep learning, segmentation and visualization. IEEE Access. 2020; 8:191586-191601.
17. Cimaglia F, Aliverti A, Chiesa M, Poltronieri P, De Lorenzis E, Santino A, Sechi LA. Quantum dots nanoparticle-based lateral flow assay for rapid detection of Mycobacterium species using anti-FprA antibodies. Nanotechnology Development. 2012; 2: 26-30. doi: 10.4081/nd.2012.e5.
18. Wu R, Zhou S, Chen T, Li J, Shen H, Chai Y, et al. Quantitative and rapid detection of C-reactive protein using quantum dot-based lateral flow test strip. Analytica Chimica Acta. 2018; 1008: 1-7. doi: 10.1016/j.aca.2017.12.031.